NCT06847945

Brief Summary

To investigate the changes of acupoint sensitization characteristics of patients with Neck Type Cervical Spondylopathy through Gallbladder meridian observe the curative effect of acupuncture intervention and optimize the clinical diagnosis and treatment plan of acupuncture treatment of Neck Type Cervical Spondylopathy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 26, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

March 5, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

February 14, 2025

Last Update Submit

February 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    The visual Analogue Scale (VAS) ranging from 0 to 10, with higher scores reflecting more pain, stiffness and poorer physical function of the Cervical. Participants were asked to evaluate their current pain, and the pain nature was marked by X on the line above. 0 was classified as painless and 10 was classified as severe pain. The higher the score, the more obvious the pain.

    Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up

Secondary Outcomes (5)

  • musculoskeletal ultrasound detection of cervical

    Before the start of treatment, immediately after the end of the third treatment

  • Pressure pain threshold

    Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up

  • The Neck Disability Index

    Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up

  • Cervical range of motion scale

    Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up

  • The 12 items Short Form Health Survey

    Before the start of treatment, immediately after the end of the third treatment, and four weeks after follow-up

Study Arms (2)

Non-meridian,non-acupoint group

SHAM COMPARATOR
Procedure: Sham acupuncture

Acupoint sensitization group

EXPERIMENTAL
Procedure: Acupuncture

Interventions

Patients in the non-meridian and non-acupoint group received sham acupuncture treatment at the position 2cm apart from the sensitized acupoint, once every other day for 30min each time, a total of 3 times for 1 week.

Non-meridian,non-acupoint group
AcupuncturePROCEDURE

Patients in acupoint sensitization group were treated with pseudoacupuncture at the sensitized points once every other day for 30min each time, a total of 3 times for 1 week.

Acupoint sensitization group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meeting the diagnostic criteria of Neck Type Cervical Spondylopathy.
  • Age 18 to 65 years old gender is not limited.
  • Clear awareness good compliance willing to cooperate with the study and accept the experimental arrangement.
  • Physical examination may or may not be accompanied by positive signs of the musculoskeletal system (including limited motor function local tender points etc.).
  • The visual analogue Scale (VAS) score was more than 3 points and less than 7 points (ranging from 0 to 10 points).
  • Informed consent and sign informed consent.

You may not qualify if:

  • Under 18 years of age or over 65 years of age;
  • weeks before the start of the experiment the relevant treatment of the disease or the use of relevant therapeutic drugs;
  • Patients with other types of cervical spondylosis (cervical radiculopathy vertebral artery type cervical spondylosis cervical myelopathy sympathetic cervical spondylosis) or with other serious organic diseases and patients with neck and shoulder pain caused by non-neck diseases;
  • Patients with cardiovascular and cerebrovascular liver kidney digestive system blood system and other serious life-threatening primary diseases or suffering from hemorrhagic diseases or skin diseases or pregnant or lactating women or have a history of cardiac pacemaker implantation;
  • Previous history of neck surgery or neck fracture;
  • Persons with confusion mental disorder or cognitive impairment;
  • The skin at the test site has scars redness swelling heat and pain that affect the test result.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third Affiliated Hospital of Zhejiang Chinese Medicine University

Hangzhou, 310000, China

Location

Related Publications (1)

  • Li C, Wang J, Shao X, Wu Y, Qu X, Cai J, He L, Yu L, Xu R, Xia Y, Wang R, Zhang L, Qiu Y. Acupuncture at Sensitized Acupoints versus Sham Acupuncture for Neck-Type Cervical Spondylosis: Study Protocol for a Randomized Controlled Trial. J Pain Res. 2025 Dec 23;18:6963-6976. doi: 10.2147/JPR.S548317. eCollection 2025.

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Chaoran Li

    The Third Affiliated hospital of Zhejiang Chinese Medical University

    STUDY CHAIR

Central Study Contacts

Chaoran Li

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

February 14, 2025

First Posted

February 26, 2025

Study Start

March 5, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 26, 2025

Record last verified: 2025-02

Locations